Ribera completed the acquisition of a 80% stake in Cardiosalus.

Ribera, a healthcare provider, completed the acquisition of a 80% stake in Cardiosalus, a heart diseases diagnosis, treatment and prevention company. Financial terms were not disclosed. "This is a very valuable addition for the expansion of the group in the Iberian Peninsula, but especially in the Region of Murcia. Personalized and precision medicine in specialized areas allows us to have the best professionals in Spain, to improve these services, transversally, in all our hospitals and clinics," Alberto de Rosa, Ribera CEO.